Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Weekly
Analytics
Immunoglobulin E news
All news on
Immunoglobulin E
(also known as
IgE
): plants, production capacities, investments and involved companies.
3 March 2026
GSK Finalizes RAPT Therapeutics Acquisition
GSK acquires ozureprubart, a potential long-acting anti-IgE therapy for food allergies, with phase IIb data expected in 2027. The deal is valued at $2.2 billion.
Who will be producing Immunoglobulin E in the future?
Find out with
chemXplore Analytics
Learn more